UPDATE 1-Bayer gains full Vitrakvi rights from Eli Lilly's Loxo By: Reuters: Company News February 15, 2019 at 11:33 AM EST * Bayer gains full control over drug Vitrakvi (larotrectinib) Read More >> Related Stocks: Bay National Corp Eli Lilly Loxo Oncology CS Rogers Corp